Member Info for comek2

Here is why I believe there is more to Roche than just validation.

In they year end update, Ncyt said it would take the 2nd year half to put production back on course, yet subsequently just 2 Monday’s ago they said they were ready to meet all demands, reiterated by the CEO in yesterday CNN interview. What explains such an impossible swift turn-around? Who plugged such huge gap in time and money? This where where Roche comes in, imo. Why would Roche validate a kit of 3rd party if there was nothing in it for them? More importantly why would ncyt (NOW) need Roche to validate when the tests have already been submitted to governments regulatory bodies in the U.K., USA, China and other countries weeks ago? b) It is these regulatory authorities that matters to the company, not Roche considering the unnecessary financial cost to nyct.

In addition, for regulatory authorities to give approval the company must demonstrate they are able to meet demands (they said they weren’t able to in end of year update referred to above) which in my view explain the ‘validation’ ie involvement of Roche.

And therefore this validation from Roche points to one thing imo: licensing/ jv (Paul Eros, ncyt business DEVELOPMENT director, worked for Roche previously).

I’ve read more 1500 posts to understand why the sp took such a hammering, although I expected mms would use the warrants to take it down as I said yesterday before market opened- but not to that extent considering the previous day big drop, in light the more positive news we are getting. I also said we should focus of the Roche news, yet the continuous posts on the sp just buried this and seem to have fed the frenzy. There is more to this company than just the coronavirus. Posting about the company leave derampers / ‘brave’ shorters rather naked of arguments, instead of feeding their appetite.

The CNN interview where the CEO says 1 week or two for approval from FDA and CFDA ( new) point to news anytime from today. Therefore I challenge those who saw it negative to give their explanation. There is more + to say about that interview and Roche validation which should take sp well up if we discuss them rather sp fluctuation.

If we discussed Roche and CNN interview this would have mitigated against such a big drop, if not reversed it. Anyway, excellent news is just around the corner; we should see good blue today as no one wants to be out this side of the weekend. I’m not ramper, I back my views with research.

If you don’t sell you haven’t made a loss and news is just around the corner. Let’s trader and mms have their day. Investors will have the last laught and dosh.

WITHOUT a test, I meant, sorry

Visaiine: “they don’t need a test- they need a cure”

How do you administer the cure with a test? Someone shows they have a flu or fever symptoms, you straightaway give them coronavirus vaccine, lol. Are you listening to health experts inc the WHO?

Some people stupidity never ceases to amaze. No wonder the CBI pressurised the government to teach literacy to 18 years + because it was costing businesses £billions yearly.

Oilboil, you think a government of the world 2nd largest economy, a member of WTO and in such worldwide crisis would want to be seen copying test? some Chinese companies have copied phones etc. But I think the Chinese wouldnt go to that extent considering the ramifications. But idiotic deramp, thanks.

I wouldn’t focus on price fluctuation but do research to feel very comfortable with my investment in ncyt, eg reread the last update, now Roche validation...and RELAX Ncyt will pay off handsomely.

To put Ncyt potential revenus in context, see how governments spend to prepare dealing with epidemic/pandemic.

“Just preparing for the pandemic can be expensive. The U.K government has spent £424 million ($708 million) on flu drug Tamiflu to tackle a flu pandemic, with £74 million having to be written off due to poor record keeping. Global sales of Tamiflu almost reached $3 billion in 2009 according to Reuters, at the height of the swine flu pandemic.”

We know China “has allocated $10 billions for diagnosis and treatment” as posted before. This will involve stockpiling, in the absence of vaccine, diagnostic tests, with ncyt having 2 Chinese distributors as per their website. Accordingly

“The best defense for a pandemic is planning. In a 2009 report, former Secretary of the U.S. Department of Health and Human Services Michael O. Leavitt wrote, "Ultimately, the key to preparing for a pandemic is to develop, stockpile, and prepare to distribute vaccines and antivirals – vaccines to prevent people from becoming infected by a virus, and antivirals to treat them if they are infected."
Swiftness of action is also essential. When SARS struck, there was criticism of China's delayed response and allegations of a cover up. But the country's reaction in 2013 to H7N9, a new form of avian flu, has been praised”

https://www.google.co.uk/amp/s/www.cnbc.com/amp/2014/02/05/counting-the-costs-of-a-global-epidemic.html

This will end up blue today, once people digest the Roche news and mms has played their tricks, mark my word.

Alansugareatyour, if you believe tests aren’t required in China. Why are you claiming to be investing in ncyt. Never seen such idiotic decamping in whole life, lol.

NCYT sells their products and service to 100 countries as per update......and as shown on their website has 58 distributors covering the whole world inc some covering several countries. They have 2 in China, 1 in Hong Kong, 3 in the USA and 2 in Japan, 3 in the Gulf countries where MERS countries- these countries are awash with oil money so spending £millions to guard against a deadly virus is peanuts.

https://www.genesig.com/about/distributors?testcss=1

Great news too all warrants have been exercised and more money the company coffers. Whether they have hit the markets, Roche validation will thwart that. The mms may play on the warrants which is a temporary blip, but Roche validation point to very interesting development.

Alansugareat, I beg to differ. Even if there is less dying, which we all hope for, people would still need to be tested to be treated if they show symptoms. What do you think will happen to the economy if people are spending more time in hospital rather in their work place? Aren’t you following the news the effect this virus is having on the world economy? Japan is at risk of recession because if the virus, China’s GDP has been lowered from 6 to 5.2 (if I recall correctly) for this quarter. China is pressuring its workforce back to work.

Another plus, Paul Eros, who has 30 years experience in the field also worked for Roche.

“Paul has over thirty years’ of experience within the field of molecular diagnostics, including strategic global marketing, sales and product management. He joins Novacyt from DiaSorin, where he was Vice President of Molecular Marketing for over five years. Paul started his career with Becton Dickinson, quickly progressing through the sales and marketing organisation in both the UK and France, before joining Roche Diagnostics in 1999, where he held a number of senior international commercial and operational roles.”

Graham Mullis, Group CEO of Novacyt, commented:

“We are delighted to welcome Paul to the Company at this important juncture in our growth. We have made significant progress growing our business-to-business channel in Primerdesign and have already signed three new design prototyping and development contracts for Q4 2017. Paul’s considerable blue-chip commercial expertise specifically in molecular diagnostics will be hugely beneficial as we aim to convert our healthy pipeline of clinical projects and B2B opportunities into new contracts.”

https://www.businesswire.com/news/home/20171002006337/en/Novacyt-Strengthens-Primerdesign-Business-New-Senior-Hire

Roche validation of Novacyst diagnosis kits is an excellent news on more than counts: an endorsement from the world no 2 top pharma- Pzifer is no 1 yet it’s one of the 2 top 10 clients of ncyt.

It’s also a brilliant message to the FDA to speed up approval, to the other countries evaluating ncyt tests kits, and to governments around the world crying out for defence against this deadly virus.

Finally there is a strong possibility that a joint venture/licensing/ maybe in sight with Roche. Why would ncyt need Roche for validation when the nhs and various U.K. hospitals, other countries’ regulators are validating their test? Will we have an additional rns this time re Roche validation? The 2 time Primerdesign updated through Twitter we had 2 rns: 1 when they posted the CE approval and the 2nd about the new IVD products.

B3HS2L, your last post is right below my post on the same topic: ncyt selling to China; so bodes well for an rns soonish, finger crossed.

Great post B2HS2L, worth pasting this bit from last May update. Ties in well with their last update on Monday saying they are selling to China. Sales/contract update should be expected soon in my view.

Graham Mullis, Group CEO of Novacyt, commented:

"I am very pleased to see this order from another new customer in China which helps to further reinforce our continued investment and success in the Asia Pacific region and provides additional opportunities for future instrument and reagent sales".

China allocates $10.26 billion to fight coronavirus for “DIAGNOSIS and treatment”, I forgot to add. There you have it: diagnosis = testing and we know they are now selling to China and already have customer from last May update. So expect an rns for a big contract very soon now they launched CE mark test, it was only 3 days ago.

https://www.google.co.uk/amp/s/mobile.reuters.com/article/amp/idUSKBN2030EE

Would Japan order NCYT tests or risk it’s economy, not to mention their people’s lives, the two bring intertwined. So ignore sp fluctuation. Good rns are just around the corner. Remember we had 2 updates rns during market hours. Will one be able to get in at reasonable price?

Japan on Brink of Recession as Economy Contracts, Virus Heightens Risk

https://www.nytimes.com/reuters/2020/02/17/business/17reuters-japan-economy-gdp.html

Considering the 1.5 billion population country, the 2nd biggest world economy won’t China throw in few £100s millions for tests to save what it is costing, see below. Ncyt is already selling to China per last update and as someone has just posted their May 2019 update, Ncyt has already a Chinese customer they sold their kits previously. What else people need to believe in the coming excellent news. Hold and don’t panic, remember last week on Tuesday sp taken down to 55p only to motor past £2. So will it do very soon.

China allocates $10.26 billion to fight coronavirus

https://www.google.co.uk/amp/s/mobile.reuters.com/article/amp/idUSKBN2030EE

China is to pump a net 150 billion yuan ($22bn; £16.3bn) into its economy on Monday to help protect it from the impact of the coronavirus outbreak.

https://www.google.co.uk/amp/s/www.bbc.co.uk/news/amp/business-51347497

After the last rns, anyone selling is a fool in my view. The rns points to several rns to come : sales contract with nhs, fda approval, HUGE sales contract from China, and some from the 30 or so countries. Save this post til next week Friday for one rns at least. You’ve been warned, lol.